8/21/25, 9:04
AM
N306 MATERNAL NEWBORN 1 & 2 notes EXAM
QUESTIONS AND ANSWERS WITH COMPLETE
SOLUTIONS VERIFIED UPDATE 2025/2026
Terms in this set (68)
Effective 6-8 hours after administration.
Mineral Oil Mineral oil interferes with absorption of fat-
soluable vitamins, and its use may
substantially reduce nutrient absorption.
Assessment
Analysis
Nursing Process Planning
Interventio
n
Evaluatio
n
Oligohydramnios is a condition that can
develop during pregnancy. It occurs when not
enough amniotic fluid, which surrounds the
fetus, is produced.
Oligohydramnios sequence is the pattern of
abnormalities that results. Amniotic fluid
Oligohydramnios being less than 300 mL during the 3rd
trimester of prengnacy. Detected during a
1/39
,8/21/25, 9:04
AM
physical exam and confirmed by an
ultrasound.
- congenital anomaly
- growth restricted
- demonstrate fetal distress during labor
Excessive amniotic fluid associated with
gastrointestinal system anomaly and
neurologic system anomaly.
Polyhydramnios - fundal height much greater than expected for
gestational age
- increase in weight gain
- urinary frequency
- gastrointestinal fetal malformations and
neurologic disorders (examples:
tracheoesophageal fistula and
anecephaly)
2/39
,8/21/25, 9:04
AM
- discontinue if contractions occurring every 1-2 minutes
and lasting 90-100 seconds.
- discontinue if contractions last longer than 90
seconds, are 2 minutes apart, have minimal or
no resting tone, or if there is an ominous or
non-reassuring FHR pattern.
- fetal monitoring must be used to
continuously monitor the fetal heart rate and
maternal contractions
- routine monitoring every 2-4 hours
Oxytocin (Pitocin) - fluctuations in blood pressure are not related
to oxytocin administration, routine
monitoring every 30-60 seconds
Side effects:
- decreased urinary output
- hypotension
- tachycardia (can cause dehydration)
Contraindicated in: positive contraction stress
test, fetus has repeated deceleration of fetal
heart in response to uterine contractions,
prolonged use of oxytocin could compromise
this fetus's oxygen supply
- ergot alkaloids
- given to stop excessive bleeding that
sometimes occurs after an abortion or
3/39
, 8/21/25, 9:04
AM
delivery
Methylergonovine - work by causing muscle of the uterus to contract
(Methergine) - elevation of blood pressure is a common side effect
- assessment prior to administration is
indicated, medication should not be given if
client's blood pressure is above 140/90
mm Hg
- a glucocorticoid that is administered IM in two
injections 24 hr apart, and requires 24 hr to be
effective. The therapeutic action is to enhance
fetal lung maturity and surfactant production
in fetuses between 24 to 34 weeks
gestation.
- promote production of fetal lung
surfactant, which is needed for adequate
respiratory function
- newborn with insufficient surfactant is at
risk for neonatal respiratory distress
syndrome
- increases maternal blood glucose and insulin
production in the fetus
Betamethasone - administer the medication deep into the
(Celestone) gluteal muscle 24 and 48 hr prior to birth of a
preterm neonate
- monitor the client and neonate for pulmonary edema
by assessing lung sounds
- monitor for maternal and neonate hyperglycemia
- monitor the neonate for heart rate changes
4/39
AM
N306 MATERNAL NEWBORN 1 & 2 notes EXAM
QUESTIONS AND ANSWERS WITH COMPLETE
SOLUTIONS VERIFIED UPDATE 2025/2026
Terms in this set (68)
Effective 6-8 hours after administration.
Mineral Oil Mineral oil interferes with absorption of fat-
soluable vitamins, and its use may
substantially reduce nutrient absorption.
Assessment
Analysis
Nursing Process Planning
Interventio
n
Evaluatio
n
Oligohydramnios is a condition that can
develop during pregnancy. It occurs when not
enough amniotic fluid, which surrounds the
fetus, is produced.
Oligohydramnios sequence is the pattern of
abnormalities that results. Amniotic fluid
Oligohydramnios being less than 300 mL during the 3rd
trimester of prengnacy. Detected during a
1/39
,8/21/25, 9:04
AM
physical exam and confirmed by an
ultrasound.
- congenital anomaly
- growth restricted
- demonstrate fetal distress during labor
Excessive amniotic fluid associated with
gastrointestinal system anomaly and
neurologic system anomaly.
Polyhydramnios - fundal height much greater than expected for
gestational age
- increase in weight gain
- urinary frequency
- gastrointestinal fetal malformations and
neurologic disorders (examples:
tracheoesophageal fistula and
anecephaly)
2/39
,8/21/25, 9:04
AM
- discontinue if contractions occurring every 1-2 minutes
and lasting 90-100 seconds.
- discontinue if contractions last longer than 90
seconds, are 2 minutes apart, have minimal or
no resting tone, or if there is an ominous or
non-reassuring FHR pattern.
- fetal monitoring must be used to
continuously monitor the fetal heart rate and
maternal contractions
- routine monitoring every 2-4 hours
Oxytocin (Pitocin) - fluctuations in blood pressure are not related
to oxytocin administration, routine
monitoring every 30-60 seconds
Side effects:
- decreased urinary output
- hypotension
- tachycardia (can cause dehydration)
Contraindicated in: positive contraction stress
test, fetus has repeated deceleration of fetal
heart in response to uterine contractions,
prolonged use of oxytocin could compromise
this fetus's oxygen supply
- ergot alkaloids
- given to stop excessive bleeding that
sometimes occurs after an abortion or
3/39
, 8/21/25, 9:04
AM
delivery
Methylergonovine - work by causing muscle of the uterus to contract
(Methergine) - elevation of blood pressure is a common side effect
- assessment prior to administration is
indicated, medication should not be given if
client's blood pressure is above 140/90
mm Hg
- a glucocorticoid that is administered IM in two
injections 24 hr apart, and requires 24 hr to be
effective. The therapeutic action is to enhance
fetal lung maturity and surfactant production
in fetuses between 24 to 34 weeks
gestation.
- promote production of fetal lung
surfactant, which is needed for adequate
respiratory function
- newborn with insufficient surfactant is at
risk for neonatal respiratory distress
syndrome
- increases maternal blood glucose and insulin
production in the fetus
Betamethasone - administer the medication deep into the
(Celestone) gluteal muscle 24 and 48 hr prior to birth of a
preterm neonate
- monitor the client and neonate for pulmonary edema
by assessing lung sounds
- monitor for maternal and neonate hyperglycemia
- monitor the neonate for heart rate changes
4/39
